Portfolio
The Cloverleaf Group’s current portfolio of companies includes:
 |
AgaMatrix, Inc. AgaMatrix develops and manufactures a line of diabetes products designed to improve the quality of diabetes care. The company’s products feature WaveSense, a new technology that personalizes each test to provide world class accuracy. It detects and corrects for many errors caused by differences in blood samples and environmental conditions. Zero-Click™, the WaveSense diabetes data management system, was designed to simplify data download. WaveSense and Zero-Click consist of six FDA-cleared products and are protected by a suite of more than 160 patents worldwide. The Cloverleaf Group is a founding investor in AgaMatrix and David Whelan is a member of the company’s Board of Directors.
|
|
Block Shield Corporation plc Block Shield Corporation is a UK public plc. Its Sunnyvale, California based subsidiary, WaveZero, has developed and holds patents for innovative solutions in the electromagnetic compatibility and radio frequency identification (RFID) fields.
|
 |
ClearPlay International NV ClearPlay is a home entertainment software system that allows viewers to screen out objectionable words and scenes from movies and pre-recorded TV programs on DVDs to suit their personal tastes. ClearPlay applies patented skip and mute technology that allows viewers to simply and intuitively watch films the way they and their families want. Beginning in 2009, ClearPlay's "Family Friendly" Home Entertainment Filtering System will be available in licensed, name-brand DVD Players via retailers in Europe. Gradually, ClearPlay will also be available worldwide in DVD and Video OnDemand platforms.
|
 |
MD Datacor Inc. MD Datacor Inc. is a leading healthcare quality measurement company headquartered in Georgia, USA that combines innovative technology with clinical information to empower payers and providers to improve care, prevent medical errors, and reduce costs. The company’s web-based solution optimizes quality by analyzing the patient medical records collected from the physicians (i.e. electronic medical records, transcribed office notes and lab results), against evidenced based clinical guidelines to identify care opportunities to the treating physician in support of quality programs. David Whelan is a member of the Board of Directors of the company.
|
 |
MEARS Technologies, Inc. Mears Technologies, Inc. is a provider of advanced silicon processes and engineering services to semiconductor device manufacturers and contract foundries. The company develops advanced CMOS solutions and associated manufacturing technology for leading-edge semiconductor chip producers and contract foundries to achieve competitive advantages at sub-micron levels. Mears Silicon Technology (MST™) offers reduced gate leakage and enhanced drive current for a variety of deep sub-micron processes. The Cloverleaf Group is a founding investor in Mears Technologies.
|
 |
Medcenter, Inc. Medcenter is the leading provider of online continuing medical education and pharmaceutical marketing services in Latin America, Iberia and the Caribbean with formal associations and endorsements from more than 250 medical associations, societies, universities and institutions representing more than 50% of all physicians of the region. The Cloverleaf Group is the largest shareholder in Medcenter and Michael Fitzgerald is Chairman and David Whelan is a member of the company’s Board of Directors. www.medcentersolutions.com
|
 |
Roxro Pharma, Inc. Roxro Pharma, Inc. is a privately-owned specialty pharmaceutical company focused on the treatment of pain. Founded in 1999, Roxro in-licenses promising drug candidates for rapid development in acute medical conditions. The Cloverleaf Group is a founding investor in Roxro Pharma and Michael Fitzgerald is a member of the company’s Board of Directors.
|
 |
Zenergy Power plc Zenergy Power plc is a global specialist manufacturer and developer of commercial applications for superconductive materials and is listed on the London Stock Exchange's AIM market (ZEN). Zenergy is highly focussed on the commercialisation of a number of energy efficient applications to be adopted in renewable energy power generation, energy distribution and large scale, energy intensive industrial processes and achieved the world’s first commercial sale of an industrial scale HTS device in September 2007. The Cloverleaf Group is a founding investor and major shareholder in Zenergy Power.
|